Supplementary Figure 2. Structural comparison of DNMT1-USP7 with individual structures
(a) Two different views of the DNMT1-USP7 complex structure shown in ribbon representation. Residues 600-614, 635-702, 855-859, 955-962, 980-983, and 1116-1132 of DNMT1 and 668-674 and 1084-1102 of USP7 are not included in the model due to absence of electron density, which may result from flexibility in the crystals. The N-and C-termini are indicated, and disconnected regions are shown as dashed lines. (d) A stereo image of the 2Fo-Fc map for the interaction between KG linker and USP7 in the DNMT1-USP7 structure at 2.9 Å contoured at 1.0.
(e) Sequence alignment of critical regions in DNMT1 (top) and USP7 (bottom) that are involved in interactions on the Interface-1. Identical and highly conserved residues are highlighted in dark background and conserved residues in grey background. Secondary structural elements are indicated above the sequences. Critical residues for the interactions are indicated in red triangles.
Supplementary Figure 3. In vitro and in vivo interactions between DNMT1 and USP7
(a) GST pull-down assay for DNMT1-USP7 interaction. Wild-type (WT) and two mutants of GST-TUD USP7 was immobilized on glutathione resin. The bound DNMT1 full-length protein was analyzed using SDS-PAGE and Coomassie blue staining.
Molecular weight markers were shown as indicated. USP7 M1 : D758A/E759A/D764A; USP7 M3 : N851A/R854A. (c) HEK293T cells were transiently transfected with Flag-DNMT1 (wild-type and mutants) followed by immunoprecipitation. The proteins were detected by immunoblotting using the indicated antibodies. As input, the whole cell lysates were analyzed by immunoblotting using the indicated antibodies. Uncropped blots are shown in Supplementary Fig. 7. (d) HEK293T cells were transiently transfected with RFP-USP7 (wild-type and mutants) and Flag-DNMT1. The interactions were detected as in Supplementary Figure 3c . As input, the whole cell lysates were analyzed by immunoblotting using the indicated antibodies. Uncropped blots are shown in Supplementary Fig. 7 . GFP-DNMT1 (wild-type and mutants) and RFP-USP7 (wild-type and mutants) were transiently expressed in HEK293T cells followed by double thymidine block. The cells were released at indicated time and used for immunofluorescence assays. DNA was visualized with DAPI staining. The representative staining is shown. The phases of the cell cycle and the percentage of the cells (among 100 cells) with representative staining are indicated. Scale bar, 5μm.
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(e) HEK293T cells were transiently transfected with Flag-DNMT1/RFP-USP7, Flag-DNMT1 4KQ /RFP-USP7, Flag-DNMT1/RFP-USP7 M1 and collected at indicated time after double-thymidine block, followed by immunoprecipitation. The proteins were detected by immunoblotting using the indicated antibodies. As input, the whole cell lysates were analyzed by immunoblotting using the indicated antibodies. Uncropped blots are shown in Supplementary Fig. 7 .
Supplementary Figure 5. USP7 deubiquitylates and stabilizes DNMT1
(a-b) DNMT1 and USP7 protein levels in HeLa cells (a), HCT116 p53 (-/-) and p53 (+/+) cells (b) with knockdown of USP7. HeLa, HCT116 p53 (-/-) and p53 (+/+) cells were infected with scramble or lentivirus expressing two independent USP7 shRNAs.
Uncropped blots are shown in Supplementary Fig. 7. (c) DNMT1 protein and mRNA levels in HCT116 cells with knockout of USP7. The HCT116 USP7 knockout cells were purchased from the Genetic Resources Core Facility of Johns Hopkins University. The protein levels were determined by immunoblotting using the indicated antibodies. The mRNA levels of DNMT1 in wild-type and USP7 knockout HCT116 cells were determined using qRT-PCR. The error bars represent ±s.d.
from triplicate experiments. Uncropped blots are shown in Supplementary Fig. 7. (d) Endogenous ubiquitination of DNMT1 regulated by USP7. HEK293T cells were infected with two independent USP7 shRNAs. DNMT1 was immunoprecipitated with DNMT1 antibody, followed by immunoblotting using the indicated antibodies.
Uncropped blots are shown in Supplementary Fig. 7 .
(e) In vitro deubiquitination of DNMT1. Flag-DNMT1 was immunoprecipitated with Anti-Flag M2 agarose and eluted with Flag peptide, followed by an in vitro deubiquitination assay using recombinant wild-type and USP7 CS proteins. The products were subjected to immunoblotting using the indicated antibodies. Uncropped blots are shown in Supplementary Fig. 7. (f) HeLa, PC-3, and A549 cells were treated with vehicle or HDAC inhibitors (TSA and MS-275) for 20 hours. The cells were further treated with 100 μg/ml CHX and harvested at the indicated time. The cell lysates were subjected to immunoblotting using the indicated antibodies. β-Actin serves as a loading control. The relative protein levels of DNMT1 were determined (compared with that of β-actin), as indicated below each panel.
Uncropped blots are shown in Supplementary Fig. 7. 
